Plus: How AI propelled Nvidia up the list and other insights from this year's survey of corporate reputations.

Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism ...

Dividend-screened portfolios of various kinds have failed to keep up with the broad US stock market over the past 10 years, ...

S&P 500 E-Mini futures (ESH25) are trending up +0.16% this morning as investors looked ahead to key U.S. inflation data and earnings reports from some of the biggest U.S. banks. In yesterday’s trading ...

On Wednesday, the foundation, now known only as Save the Music Foundation, announced its intention to “go indie” — ...

At the center of the scheme is a group of corporate actors known as Pharmacy Benefit Managers ... But by 2023, the company ...

Just days before ending his 24-year tenure as president and CEO of Direct Relief, Thomas Tighe was still so energized talking ...

It operates Lilly Seaport Innovation Center (LSC), a research and development facility in the Boston Seaport to advancing Lilly's efforts in RNA and DNA-based therapies as well as discovering new ...

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...

2024 was an interesting year for pharmaceutical powerhouse Eli Lilly (NYSE: LLY). At one point, share prices had gained as much as 65% on the year. However, after a less-than-spectacular earnings ...

Daniel Ghinn explores the processes behind launching LillyPad, global pharmaceutical company Eli Lilly’s corporate blog, which has associated social media channels on YouTube, Facebook and Twitter.